BioAdaptives, Inc.
BDPT
$0.01
$0.00-14.06%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 126.09% | 43.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 126.09% | 43.75% | |||
| Cost of Revenue | 250.00% | -63.64% | |||
| Gross Profit | 94.87% | 254.55% | |||
| SG&A Expenses | -5.15% | -4.05% | |||
| Depreciation & Amortization | 0.00% | 50.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.37% | -4.28% | |||
| Operating Income | 6.62% | 4.84% | |||
| Income Before Tax | -116.94% | -140.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -116.94% | -140.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -116.94% | -140.34% | |||
| EBIT | 6.62% | 4.84% | |||
| EBITDA | 6.66% | 5.20% | |||
| EPS Basic | -84.37% | -123.49% | |||
| Normalized Basic EPS | -51.02% | -182.69% | |||
| EPS Diluted | -84.37% | -123.49% | |||
| Normalized Diluted EPS | -51.02% | -182.69% | |||
| Average Basic Shares Outstanding | 17.49% | 7.40% | |||
| Average Diluted Shares Outstanding | 17.49% | 7.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||